Itisestimatedthatasmanyas30%ofpeoplewithfoodallergy(FA)sufferfrommultipleFAs.Theimmune mechanisms underlying different clinical outcomes of oral immunotherapy (OIT) are not well understood, particularly in multi-food allergic individuals, and it is not clear to what extent combining OIT with other immunomodulatingtherapiesmightimprovethesafetyorefficacyofOITinFA,orthedurabilityoffavorable clinicaloutcomes.ThereisanunmetneedfornewtherapiesinFA,sinceOITisassociatedwithrefractoryor fail-to-treatpopulations,likelyduetoanumberofcellularandmolecularendotypesandclinicalphenotypes. BecausethecytokinesIL-4andIL-13areimportantimmunedriversofFAthatactupstreamofIgEingenerating anallergicresponse,toaddressthesechallenges,ourapproachistoconductapilot,phase2,multiplefood allergenOIT(mOIT)studytocomparethesafety,efficacyanddurabilityofmOITcombinedwiththeanti-IL- 4R? antibody dupilumab (DmO) vs. mOIT alone, and vs. mOIT combined with the anti-IgE antibody, omalizumab(OmO).Wehypothesizethatsuchcombinationtherapycouldimprovethesafety,efficacyand/or durabilityofmOITinmulti-FApatients.WealsohypothesizethatDmO,butnotOmO,willimprovesustained unresponsivenessoutcomesvs.mOITalone,duetotheeffectsofdupilumabontheactionsofIL-4andIL-13. Our study will provide samples at screening, throughout OIT, and long-term after OIT, for key bioassays in Projects 2 (B cells), 3 (T cells) and 4 (basophils). Our study thus offers an arguably unique opportunity to achieve our overall objective: creating a comprehensive dataset of the clinical and immune monitoring outcomesofOITprotocolstobetterunderstandmechanismsofFAandtoimprovethesafetyandefficacyof FAtherapy.
Our specificaims areto:1)TestwhethertreatmentwithmOITcombinedwitheitheromalizumab ordupilumabvs.mOITaloneresultsinahigherproportionofparticipantsbeingabletopassafoodchallenge atweek24(primaryendpoint)andafteraperiodofallergenwithdrawalatweek30(asecondaryendpoint);? 2)DeterminewhethertheseOITprotocolshavelastingeffectsontheefficacyandsafetyofthesetreatments, andonchangesinthesubjects'immuneresponsesthatwereinducedbysuchtreatments;?and3)ObtainGI biopsiesofparticipantstopermitadetailedanalysisofimmunecellsandtheirproductsinGItissues,atentry intothetrialtoidentifyfeaturesassociatedwithFAatthediseasesite,andoverthecourseofOITtoevaluate whetherandhowthesefeaturesmightchange.Project1willbethefirststudytoevaluateandcompareeach immunomodulatingdrugcombinedwithmOITvs.mOITalone:thenoveltyofthestudydesigncombinedwith detailedmechanisticstudiesofbloodandGIbiopsieswillpermitustoadvancethemechanisticunderstanding ofFAandOIT,andtoestablishmoreeffectiveandsaferapproachestoFAtreatment.
| Hartmann, Felix J; Simonds, Erin F; Bendall, Sean C (2018) A Universal Live Cell Barcoding-Platform for Multiplexed Human Single Cell Analysis. Sci Rep 8:10770 |
| Klein, Ofir; Roded, Amit; Hirschberg, Koret et al. (2018) Imaging FITC-dextran as a Reporter for Regulated Exocytosis. J Vis Exp : |
| Zhang, Wenming; Lin, Chunrong; Sampath, Vanitha et al. (2018) Impact of allergen immunotherapy in allergic asthma. Immunotherapy 10:579-593 |
| Sampath, Vanitha; Sindher, Sayantani B; Zhang, Wenming et al. (2018) New treatment directions in food allergy. Ann Allergy Asthma Immunol 120:254-262 |
| Sindher, Sayantani B; Long, Andrew; Acharya, Swati et al. (2018) The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses. Clin Rev Allergy Immunol 55:190-204 |
| Mukai, Kaori; Tsai, Mindy; Saito, Hirohisa et al. (2018) Mast cells as sources of cytokines, chemokines, and growth factors. Immunol Rev 282:121-150 |
| Keren, Leeat; Bosse, Marc; Marquez, Diana et al. (2018) A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. Cell 174:1373-1387.e19 |
| Chinthrajah, R Sharon; Purington, Natasha; Andorf, Sandra et al. (2018) Development of a tool predicting severity of allergic reaction during peanut challenge. Ann Allergy Asthma Immunol 121:69-76.e2 |
| Andorf, Sandra; Purington, Natasha; Block, Whitney M et al. (2018) Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial. Lancet Gastroenterol Hepatol 3:85-94 |
| Tsai, Cheng-Ting; Mukai, Kaori; Robinson, Peter V et al. (2018) Isotype-specific agglutination-PCR (ISAP): A sensitive and multiplex method for measuring allergen-specific IgE. J Allergy Clin Immunol 141:1901-1904.e15 |
Showing the most recent 10 out of 53 publications
